Category: Pharma News

D & C Act अधिनियम के उल्लंघन में दवाओं को स्टॉक करने और बेचने के लिए DCGI ने e-Pharmacy को नोटिस जारी किया

Online pharmacies, including Tata 1mg, have received a show cause notice from the Drug Controller General of India (DCGI) for allegedly stocking and selling drugs in violation of the Drugs and Cosmetics Act, 1940 and Rules. This has once again…

All India Drug and Chemist Organization द्वारा DCGI को दवई के स्ट्रिप कटिंग में  नियंत्रण लाने की सलाह दी गई

Strip cutting of medications has been a significant problem for lakhs of pharmaceutical sellers in the nation, one that has eluded a permanent resolution because to the drug authorities’ callous attitude. Arguments and counterarguments have long flown thick and fast…

AMJEVITA™ (adalimumab-atto), first biosimilar to Humira® now available in the United States

Amgen (NASDAQ:AMGN) today announced AMJEVITA™ (adalimumab-atto), a biosimilar to Humira®* (adalimumab), is now available in the United States. AMJEVITA was the first biosimilar to Humira approved by the U.S. Food and Drug Administration (FDA), in 2016.(1,2)“With today’s announcement, AMJEVITA is…

Back to top

Registration Form


This will close in 0 seconds

This will close in 0 seconds

WhatsApp Join Telegram